paclitaxel has been researched along with Cancer of the Vulva in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Andreetta, C; Bartoletti, M; Bonotto, M; Bortot, L; Corsetti, S; De Scordilli, M; De Vivo, R; Del Fabro, A; Fasola, G; Giorda, G; Mazzeo, R; Meacci, ML; Nicoloso, MS; Puglisi, F; Scalone, S; Sopracordevole, F; Sorio, R; Vitale, MG | 1 |
| Avril, MF; Isnard, C; Moyal-Barracco, M; Plantier, F; Thériaut, M | 1 |
| Adorni, M; Bazzurini, L; Buda, A; Grassi, T; Landoni, F; Lissoni, AA; Negri, S; Vecchione, F | 1 |
| Gao, X; Huang, M; Li, Q; Niu, Y; Wang, D; Yin, R | 1 |
| Amant, F; Annibali, D; Goffin, F; Han, S; Nooij, L; van den Bulck, H; van Rompuy, AS | 1 |
| Funakoshi, T; Hirai, I; Ishii, M; Kawakami, Y; Nakamura, Y; Tanese, K | 1 |
| Cliby, WA; Janco, JM; Markovic, SN; Weaver, AL | 1 |
| Nautiyal, V; Pandey, KC; Pant, NK; Revannasiddaiah, S | 1 |
| Ando, N; Harada, K; Inozume, T; Kawamura, T; Matsuzawa, M; Onuma, T; Sano, S; Shimada, S | 1 |
| Chen, JR; Tzen, CY; Yang, YC | 1 |
| Coens, C; Demonty, G; Guerra, C; Reed, N; Scarabeli, C; van der Velden, J; Vergote, I; Witteveen, PO | 1 |
| Amaral, N; de Oliveira, CF; Domingues, AP; Durão, M; Frutuoso, C; Mota, F | 1 |
| Amant, F; Han, SN; Vergote, I | 1 |
| Alexis, M; Awonuga, AO; Belotte, J; Bolinjkar, R; Deppe, G; Tabassum, F | 1 |
| Grénman, R; Grénman, S; Helenius, H; Kulmala, J; Raitanen, M; Rantanen, V | 1 |
| Cooper, DL; Higgins, SA; Kluger, HM; Murren, JR; Noronha, V | 1 |
| Grénman, R; Grénman, S; Jaakkola, M; Kulmala, J; Rantanen, V | 1 |
| Amo-Takyi, BK; Boabang, P; Kohlhagen, H; Kurbacher, CM; Waida, A | 1 |
| Kris, MG; Miller, VA; Scher, HI; Sirotnak, FM; Zakowski, MF | 1 |
| Grénman, R; Grénman, S; Klemi, P; Kulmala, J; Pulkkinen, J; Raitanen, M; Rantanen, V | 1 |
| Kim, RY | 1 |
1 review(s) available for paclitaxel and Cancer of the Vulva
| Article | Year |
|---|---|
Recent advances in the treatment of gynecologic malignancies: an overview of the GOG phase III trials.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Endometrial Neoplasms; Female; Humans; Neoadjuvant Therapy; Ovarian Neoplasms; Paclitaxel; Treatment Outcome; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2002 |
2 trial(s) available for paclitaxel and Cancer of the Vulva
| Article | Year |
|---|---|
Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Grou
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Vulvar Neoplasms | 2009 |
Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pilot Projects; Prognosis; Prospective Studies; Vulvar Neoplasms | 2012 |
18 other study(ies) available for paclitaxel and Cancer of the Vulva
| Article | Year |
|---|---|
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.
Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Fatal Outcome; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Off-Label Use; Paclitaxel; Paget Disease, Extramammary; Receptor, ErbB-2; Trastuzumab; Vulvar Neoplasms | 2020 |
Complete but transient clinical remission of vulvar Paget's disease with paclitaxel and trastuzumab.
Topics: Female; Humans; Middle Aged; Paclitaxel; Paget Disease, Extramammary; Trastuzumab; Vulvar Neoplasms | 2021 |
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Retrospective Studies; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2022 |
Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: A STROBE-compliant article.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administration Schedule; Female; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Prognosis; Survival Analysis; Treatment Outcome; Vincristine; Vulvar Neoplasms | 2018 |
Brief Report on 3-Weekly Paclitaxel Carboplatin Efficacy in Locally Advanced or Metastatic Squamous Vulvar Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Prospective Studies; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2018 |
Combination Cisplatin-Epirubicin-Paclitaxel Therapy for Metastatic Extramammary Paget's Disease.
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Female; Genital Neoplasms, Male; Humans; Male; Middle Aged; Neutropenia; Paclitaxel; Paget Disease, Extramammary; Prognosis; Progression-Free Survival; Retrospective Studies; Scrotum; Severity of Illness Index; Thrombocytopenia; Vulvar Neoplasms | 2019 |
Vulvar and vaginal melanoma: case series and review of current management options including neoadjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Dacarbazine; Female; Humans; Lymphatic Metastasis; Melanoma; Neoadjuvant Therapy; Paclitaxel; Survival Rate; Temozolomide; Treatment Outcome; Vaginal Neoplasms; Vulvar Neoplasms | 2013 |
Vulvar adenocarcinoma: visual resemblance to a vulvar abscess.
Topics: Abscess; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diagnosis, Differential; Fatal Outcome; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Paclitaxel; Vulvar Diseases; Vulvar Neoplasms | 2013 |
A case of recurrent squamous cell carcinoma of the vulva successfully treated by combination therapy with cetuximab and paclitaxel.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Vulvar Neoplasms | 2016 |
Metronomic paclitaxel and thalidomide for rapidly metastatic primary vulvar malignant rhabdoid tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Paclitaxel; Pleural Neoplasms; Rhabdoid Tumor; Thalidomide; Vulvar Neoplasms; Young Adult | 2009 |
Neoadjuvant chemotherapy in advanced vulvar cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bleomycin; Carcinoma; Cisplatin; Female; Fluorouracil; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Portugal; Retrospective Studies; Survival Rate; Treatment Outcome; Vulvar Neoplasms | 2010 |
Platinum-based combination chemotherapy for the treatment of advanced-stage squamous cell carcinoma of the vulva.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; HIV; HIV Infections; Humans; Middle Aged; Paclitaxel; Remission Induction; Taxoids; Vulvar Neoplasms | 2012 |
Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Paclitaxel; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vulvar Neoplasms | 2002 |
Metastatic myoepithelial carcinoma of the vulva treated with carboplatin and paclitaxel.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Female; Humans; Lymphatic Metastasis; Myoepithelioma; Paclitaxel; Treatment Outcome; Vulvar Neoplasms | 2006 |
In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Linear Models; Paclitaxel; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vulvar Neoplasms | 1996 |
Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Etoposide; Female; Humans; Luminescent Measurements; Paclitaxel; Topotecan; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2000 |
Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase.
Topics: Aminopterin; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carboplatin; Cell Division; Cisplatin; Docetaxel; Dose-Response Relationship, Drug; ErbB Receptors; Female; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Male; Maximum Tolerated Dose; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Prostatic Neoplasms; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Taxoids; Time Factors; Tumor Cells, Cultured; Vinblastine; Vinorelbine; Vulvar Neoplasms | 2000 |
Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines.
Topics: Carcinoma, Squamous Cell; Cell Survival; Combined Modality Therapy; Dose Fractionation, Radiation; Female; Humans; In Vitro Techniques; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vulvar Neoplasms | 2002 |